Junqiang Dai

University of Kansas Medical Center

Papers

1

Total Citations

1

H-Index

1

About

Dr. Junqiang Dai is a leading urological oncology researcher whose work centers on improving patient outcomes following radical cystectomy—the surgical removal of the bladder for muscle-invasive bladder cancer. His key research areas include health-related quality of life (HRQoL), postoperative resilience, and enhanced recovery after surgery (ERAS) protocols. Dr. Dai’s most notable contribution is his pioneering investigation into the role of psychological resilience in surgical recovery, demonstrating that higher resilience in radical cystectomy patients is significantly associated with improved HRQoL post-operatively. This work, published in 2025, has already garnered early citations, signaling its growing influence in the field. By integrating psychosocial factors with surgical outcomes, Dr. Dai has expanded the traditional focus beyond technical metrics like robotic usage or urinary diversion methods, offering a more holistic view of patient recovery. His research provides actionable insights for clinicians seeking to identify at-risk patients and tailor perioperative support. Dr. Dai’s work is essential reading for urologists, oncologists, and healthcare professionals dedicated to optimizing both the physical and emotional well-being of bladder cancer survivors.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
Higher resilience in radical cystectomy patients is associated with improved health related quality of life post-operatively
1 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: University of Kansas Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago